Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹772 Cr₹781 Cr₹1,212 Cr₹997 Cr₹773 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹772 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹772 Cr
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr
Mar2021₹773 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹772 Cr
-1.10
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr
29.00
Mar2021 ₹773 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,482.9 Cr -2.9% 0.1% 0.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹111,299.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -2% -8.8% -12.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.9%

0.1%

0.4%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses